Espellere liscio fessura clinical sarcoma research impact factor struttura etichetta rivolta
Epidemiology of Soft Tissue Sarcoma and Bone Sarcoma inItaly: Analysis of Data from 15 Population-Based Cancer Registries
The Epidemiology of Sarcoma | Clinical Sarcoma Research | Full Text
Soft Tissue Sarcoma Types, Staging & Treatment - Dana-Farber Cancer Institute | Boston, MA
Oncology and Cancer Therapeutics Journals | Oncology Research Journals
Clinical genomic profiling in the management of patients with soft tissue and bone sarcoma | Nature Communications
Sarcomas: Immune biomarker expression and checkpoint inhibitor trials - Cancer Treatment Reviews
Sarcoma | Hindawi
Survival impact of centralization and clinical guidelines for soft tissue sarcoma (A prospective and exhaustive population-based cohort) | PLOS ONE
Cancer Research Journal | Peer Reviewed | High Impact
A Critical Review of the Impact of Sarcoma on Psychosocial Wellbeing
A clinico-genomic analysis of soft tissue sarcoma patients reveals CDKN2A deletion as a biomarker for poor prognosis | Clinical Sarcoma Research | Full Text
Soft‐tissue sarcoma in adults: An update on the current state of histiotype‐specific management in an era of personalized medicine - Gamboa - 2020 - CA: A Cancer Journal for Clinicians - Wiley Online Library
Frontiers | Intra-Abdominal Desmoplastic Small Round Cell Tumor: Current Treatment Options and Perspectives
Sarcoma treatment in the era of molecular medicine | EMBO Molecular Medicine
Childhood Soft Tissue Sarcoma Treatment (PDQ®)–Health Professional Version - NCI
Survival impact of centralization and clinical guidelines for soft tissue sarcoma (A prospective and exhaustive population-based cohort) | PLOS ONE
Clinical Oncology Journals | Cancer Research |High Impact Factor
Frontiers | Anlotinib: A Novel Targeted Drug for Bone and Soft Tissue Sarcoma
Clinical Sarcoma Research
Soft tissue and visceral sarcomas: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up† - Annals of Oncology
Molecular mechanisms underpinning sarcomas and implications for current and future therapy | Signal Transduction and Targeted Therapy
Molecular mechanisms underpinning sarcomas and implications for current and future therapy | Signal Transduction and Targeted Therapy
A clinico-genomic analysis of soft tissue sarcoma patients reveals CDKN2A deletion as a biomarker for poor prognosis | Clinical Sarcoma Research | Full Text
Genomic identification of sarcoma radiosensitivity and the clinical implications for radiation dose personalization - ScienceDirect